Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Immunitas Therapeutics
650 East Kendall Street, 2nd Fl
Cambridge, MA 02142
Phone: 781-810-9292

Immunitas Therapeutics, founded by Longwood Fund, employs a single cell genomics platform to dissect the biology of immune cells in human tumors, thereby advancing discoveries directly from the bench into meaningful clinical improvements. Our focus on human data allows us to start with and stay closer to the biology that is most relevant in patients and greatly accelerates the pace of our research. The Immunitas team of scientific pioneers innovates around each step of the drug development process, first identifying novel targets, then designing therapeutic strategies, and developing key biomarkers to guide the selection of patients who may benefit from our new drugs.

Key Contact
Name
Lea Hachigian, Ph.D.
Title
Co-Founder & President
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/21/19 $39,000,000 Series A Alexandria Venture Investments
Evotec
Leaps by Bayer
M Ventures
Novartis Venture Funds
undisclosed
08/18/21 $58,000,000 Series B 120 Capital
Agent Capital
Alexandria Venture Investments
BrightEdge Ventures
Evotec
Medical Excellence Capital
Mirae Asset Venture Investment
NS Investment
Ono Venture Investment
Solasta Ventures
The Leukemia & Lymphoma Society
The Mark Foundation for Cancer Research
undisclosed